North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Forecast to 2028

North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Mouthpiece PEP Devices, Face Mask PEP Devices, and Bottle PEP Devices), Indication [Chronic Obstructive Pulmonary Disease (COPD), Asthma, Bronchitis, Bronchiectasis, Cystic Fibrosis, and Others], and Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies)

Report Code : BMIRE00025372 | Region : North America | Industry : Medical Device | Published Date : 15/Jul/2022

The North America oscillating positive expiratory pressure (OPEP) devices market is expected to grow from US$ 91.82 million in 2021 to US$ 64.70 million by 2028; it is estimated to grow at a CAGR of 5.1% from 2021 to 2028.

The incidence of chronic obstructive pulmonary disease (COPD) and cystic fibrosis is rising across the region. As per the World Health Organization (WHO), exacerbations of COPD are critical events in the history of COPD. Further, COPD-related disability and mortality propel the demand for oscillating positive expiratory pressure (OPEP) devices. Moreover, according to the Center for Disease Control and Prevention (CDC), ~9 million adults were diagnosed with chronic bronchitis in 2018. Further, asthma is becoming common among people of all ages, genders, and races. According to CDC, ~300 million people worldwide have asthma, with an additional 100 million expected by 2025. The prevalence, severity, and mortality of asthma vary dramatically across the US. Asthma affects over 25 million people in the US, which equates to 7.7% of adults and 8.4% of children. Asthma is common in high-income nations, whereas the majority of asthma-related deaths occur in low- and middle-income countries. Therefore, the rising prevalence of COPD and asthma propel the demand for mucous clearing devices, such as OPEP devices, which bolsters the growth of the North America oscillating positive expiratory pressure (OPEP) devices market.

With new features and advanced technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America oscillating positive expiratory pressure (OPEP) devices market at a notable CAGR during the forecast period.

North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Revenue and Forecast to 2028 (US$ Million)

North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Segmentation

The North America oscillating positive expiratory pressure (OPEP) devices market is segmented into product, indication, distribution channel, and country. Based on product, the market is segmented into mouthpiece PEP devices, face mask PEP devices, and bottle PEP devices. In 2021, the mouthpiece PEP devices segment accounted for the largest market share; and it is likely to register the highest CAGR during the forecast period. Based on indication, the market is categorized into chronic obstructive pulmonary disease (COPD), asthma, bronchitis, bronchiectasis, cystic fibrosis, and others. In 2021, the chronic obstructive pulmonary disease (COPD) segment accounted for the largest share of the market; however, the asthma segment is likely to register the highest CAGR during the forecast period. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2021, the hospital pharmacies segment held the largest market share; however, the retail pharmacies segment is expected to register the highest CAGR in the market during the forecast period. Further, based on country, the North America market is segmented into the US, Canada, and Mexico. In 2021, the US held the largest market share; and it is expected to register the highest CAGR during the forecast period.

Allergan Plc.; PARI GmbH; Smiths Medical; AirPhysio; Mercury Medical; D•R BURTON HEALTHCARE; and Medica Holdings, LLC are among some of the leading companies operating in the North America oscillating positive expiratory pressure (OPEP) devices market.

Mouthpiece PEP Devices Segment to Dominate the North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market During 2021–2028

According to a new market research study on “North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Product, Indication, and Distribution Channel ” the market is expected to reach US$ 91.82 million by 2028 from US$ 64.70 million in 2021. The market is estimated to grow at a CAGR of 5.1% from 2021 to 2028. The report provides trends prevailing in the North America oscillating positive expiratory pressure (OPEP) devices market along with the drivers and restraints pertaining to the market growth. Increasing prevalence of chronic obstructive pulmonary disease (COPD) and asthma, surging technological advancements, and burgeoning funding for research and development activities are the major factor driving the growth of the North America oscillating positive expiratory pressure (OPEP) devices market . However, restricted awareness and limited access to OPEP devices hinders the growth of North America oscillating positive expiratory pressure (OPEP) devices market .

The North America oscillating positive expiratory pressure (OPEP) devices market is segmented on the basis of product, indication, distribution channel, and country. Based on product, the market is segmented into mouthpiece PEP devices, face mask PEP devices, and bottle PEP devices. In 2021, the mouthpiece PEP devices segment accounted for the largest market share; and it is likely to register the highest CAGR during the forecast period. Based on indication, the market is categorized into chronic obstructive pulmonary disease (COPD), asthma, bronchitis, bronchiectasis, cystic fibrosis, and others. In 2021, the chronic obstructive pulmonary disease (COPD) segment accounted for the largest share of the market; however, the asthma segment is likely to register the highest CAGR during the forecast period. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. In 2021, the hospital pharmacies segment held the largest market share; however, the retail pharmacies segment is expected to register the highest CAGR in the market during the forecast period. Further, based on country, the North America oscillating positive expiratory pressure (OPEP) devices market is segmented into the US, Canada, and Mexico. In 2021, the US held the largest market share; and it is also expected to grow at the fastest CAGR during the forecast period.

Allergan Plc.; PARI GmbH; Smiths Medical; AirPhysio; Mercury Medical; D•R BURTON HEALTHCARE; and Medica Holdings, LLC are among some of the leading companies in the North America oscillating positive expiratory pressure (OPEP) devices market. For instance, Intalere has given D-R Burton Healthcare a deal for their iPEP and PocketPEP Oscillating Positive Expiratory Pressure devices. After the iPEP and PocketPEP were shown at the Intalere Emerging Technology Expo held during the company's annual member conference, the agreement was awarded, providing negotiated price to Intalere members.

TABLE OF CONTENTS

1. Introduction

1.1 Study Scope

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market – By Product

1.3.2 North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market – By Indication

1.3.3 North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market – By Distribution Channel

1.3.4 North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market – By Country

2. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinions

5. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market– Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and Asthma

5.1.2 Surging Technological Advancements

5.2 Market Restraints

5.2.1 Restricted Awareness and Limited Access to OPEP Devices

5.3 Market Opportunities

5.3.1 Growing Demand for Non-Pharmacological Treatment Methods for Increasing Mobilization

5.4 Future Trends

5.4.1 Burgeoning Funding for Research and Development Activities

5.5 Impact analysis

6. North America Increasing Oscillating Positive Expiratory Pressure (OPEP) Devices Market Analysis

6.1 North America Increasing Oscillating Positive Expiratory Pressure (OPEP) Devices Market

7. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market – by Product

7.1 Overview

7.2 North America Product Market Revenue and Forecast Analysis (US$ Mn)

7.3 Mouthpiece PEP Devices

7.3.1 Overview

7.3.2 Mouthpiece PEP Devices Revenue and Forecast to 2028 (US$ Mn)

7.4 Face Mask PEP Devices

7.4.1 Overview

7.4.2 Face Mask PEP Devices Revenue and Forecast to 2028 (US$ Mn)

7.5 Bottle PEP Devices

7.5.1 Overview

7.5.2 Bottle PEP Devices Revenue and Forecast to 2028 (US$ Mn)

8. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market – by Indication

8.1 Overview

8.2 North America Indication Market Revenue and Forecast Analysis (US$ Mn)

8.3 Chronic obstructive pulmonary disease (COPD)

8.3.1 Overview

8.3.2 Chronic obstructive pulmonary disease (COPD) Market Revenue and Forecast to 2028 (US$ Mn)

8.4 Asthma

8.4.1 Overview

8.4.2 Asthma Market Revenue and Forecast to 2028 (US$ Mn)

8.5 Bronchitis

8.5.1 Overview

8.5.2 Bronchitis Market Revenue and Forecast to 2028 (US$ Mn)

8.6 Cystic Fibrosis

8.6.1 Overview

8.6.2 Cystic Fibrosis Market Revenue and Forecast to 2028 (US$ Mn)

8.7 Bronchiectasis

8.7.1 Overview

8.7.2 Bronchiectasis Market Revenue and Forecast to 2028 (US$ Mn)

8.8 Others

8.8.1 Overview

8.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

9. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market – by Distribution Channel

9.1 Overview

9.2 North America Distribution Channel Market Revenue and Forecast Analysis (US$ Mn)

9.3 Hospital Pharmacies

9.3.1 Overview

9.3.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

9.4 Retail Pharmacies

9.4.1 Overview

9.4.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

9.5 Online Pharmacies

9.5.1 Overview

9.5.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

10. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market – Country Analysis

10.1 Overview

10.1.1 North America: Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Country, 2021 & 2028 (%)

10.1.1.1 US: Oscillating Positive Expiratory Pressure (OPEP) Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1 Overview

10.1.1.1.2 US: Oscillating Positive Expiratory Pressure (OPEP) Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3 US Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Product– Revenue and Forecast to 2028 (USD Million)

10.1.1.1.4 US Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.5 US Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

10.1.1.2 Canada: Oscillating Positive Expiratory Pressure (OPEP) Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1 Overview

10.1.1.2.2 Canada: Oscillating Positive Expiratory Pressure (OPEP) Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.3 Canada Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Product– Revenue and Forecast to 2028 (USD Million)

10.1.1.2.4 Canada Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.5 Canada Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

10.1.1.3 Mexico: Oscillating Positive Expiratory Pressure (OPEP) Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1 Overview

10.1.1.3.2 Mexico: Oscillating Positive Expiratory Pressure (OPEP) Devices Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3 Mexico Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Product– Revenue and Forecast to 2028 (USD Million)

10.1.1.3.4 Mexico Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Indication – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.5 Mexico Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

11. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market – Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Allergan Plc.

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 PARI GmbH

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Smiths Medical

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 AirPhysio

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 D•R BURTON HEALTHCARE

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 Medica Holdings, LLC

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Trudell Medical International

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 Mercury Medical

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms in North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market

LIST OF TABLES.

Table 1. US Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Product – Revenue and Forecast to 2028 (USD Million)

Table 2. US Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 3. US Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 4. Canada Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Product-Revenue and Forecast to 2028 (USD Million)

Table 5. Canada Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Indication -Revenue and Forecast to 2028 (USD Million)

Table 6. Canada Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 7. Mexico Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Product -Revenue and Forecast to 2028 (USD Million)

Table 8. Mexico Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Indication -Revenue and Forecast to 2028 (USD Million)

Table 9. Mexico Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 10.   Recent Inorganic Growth Strategies in the Oscillating Positive Expiratory Pressure (OPEP) Devices Market

Table 11.   Recent Organic Growth Strategies in the Oscillating Positive Expiratory Pressure (OPEP) Devices Market

Table 12.   Glossary of Terms

LIST OF FIGURES.

Figure 1. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Segmentation

Figure 2. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Segmentation, By Country

Figure 3. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Overview

Figure 4. Mouthpiece PEP Devices Segment Held Largest Share of Oscillating Positive Expiratory Pressure (OPEP) Devices Market

Figure 5. The US to Show Significant Growth During Forecast Period

Figure 6. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market, Industry Landscape

Figure 7. North America PEST Analysis

Figure 8. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market Impact Analysis of Drivers and Restraints

Figure 9. North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 10.   North America Product Market Analysis and Forecast 2021 and 2028 (%)

Figure 11.   Mouthpiece PEP Devices Revenue and Forecast to 2028 (US$ Mn)

Figure 12.   Face Mask PEP Devices Revenue and Forecast to 2028 (US$ Mn)

Figure 13.   Bottle PEP Devices Revenue and Forecast to 2028 (US$ Mn)

Figure 14.   North America Indication Market Analysis and Forecast 2021 and 2028 (%)

Figure 15.   Chronic obstructive pulmonary disease(COPD) Market Revenue and Forecast to 2028 (US$ Mn)

Figure 16.   Asthma Market Revenue and Forecast to 2028 (US$ Mn)

Figure 17.   Bronchitis Market Revenue and Forecast to 2028 (US$ Mn)

Figure 18.   Cystic Fibrosis Market Revenue and Forecast to 2028 (US$ Mn)

Figure 19.   Bronchiectasis Market Revenue and Forecast to 2028 (US$ Mn)

Figure 20.   Others Market Revenue and Forecast to 2028 (US$ Mn)

Figure 21.   North America Distribution Channel Market Analysis and Forecast 2021 and 2028 (%)

Figure 22.   Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

Figure 23.   Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

Figure 24.   Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)

Figure 25.   North America: Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Key Country – Revenue (2021) (USD Million)

Figure 26.   North America: Oscillating Positive Expiratory Pressure (OPEP) Devices Market, by Country, 2021 & 2028 (%)

Figure 27.   US: Oscillating Positive Expiratory Pressure (OPEP) Devices Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.   Canada: Oscillating Positive Expiratory Pressure (OPEP) Devices Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.   Mexico: Oscillating Positive Expiratory Pressure (OPEP) Devices Market – Revenue and Forecast to 2028 (USD Million)

The List of Companies - North America Oscillating Positive Expiratory Pressure (OPEP) Devices Market

● Allergan Plc.

● PARI GmbH

● Smiths Medical

● AirPhysio

● Mercury Medical   

● D•R BURTON HEALTHCARE                                         

● Medica Holdings, LLC

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America oscillating positive expiratory pressure (OPEP) devices market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the North America oscillating positive expiratory pressure (OPEP) devices market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth North America market trends and outlook coupled with the factors driving the oscillating positive expiratory pressure (OPEP) devices market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

TOP